Company Filing History:
Years Active: 2023-2025
Title: Yuhang Liu: Innovator in Cytomegalovirus Research
Introduction
Yuhang Liu is a notable inventor based in South Glastonbury, Connecticut. He has made significant contributions to the field of virology, particularly in the study of human cytomegalovirus (HCMV). With a total of three patents to his name, Liu's work has implications for vaccine development and therapeutic interventions.
Latest Patents
Liu's latest patents focus on the human cytomegalovirus glycoprotein B (gB) polypeptide. One of his inventions includes polypeptides and cytomegalovirus antigens that feature at least two introduced amino acid mutations compared to the wild-type HCMV glycoprotein B. These polypeptides are stabilized in a conformation alternative to the gB postfusion conformation. Another patent involves mutants of the wild-type cytomegalovirus glycoprotein B that also include similar amino acid mutations, with compositions and uses that enhance their stability and efficacy.
Career Highlights
Yuhang Liu is currently employed at Pfizer Corporation, where he continues to advance his research in virology. His work at Pfizer has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Liu's notable coworkers include Xiaoyuan Sherry Chi and Jennifer Anne Nicki. Their collaborative efforts have further enriched the research environment and fostered innovation in their projects.
Conclusion
Yuhang Liu's contributions to the field of cytomegalovirus research exemplify the impact of innovative thinking in medicine. His patents and ongoing work at Pfizer Corporation highlight the importance of scientific research in developing effective treatments.